GlobalData
GlobalData

Medical Devices

International Diabetes Day highlights urgent need for early detection and equitable care, says GlobalData

Rising global diabetes rates are intensifying calls for earlier detection and fairer access to care, signalling how health systems must evolve to manage escalating clinical and economic pressures. This year’s International Diabetes Day on 14 November spotlights persistent treatment gaps, the expanding role of technology-enabled monitoring, and the policy action needed to prevent complications and […]
Read more

GLP-1 evidence signals shift in future dialysis care in US, says GlobalData

Emerging evidence that GLP-1 therapies can slow chronic kidney disease (CKD) progression is reshaping expectations for renal care demand in the US. As semaglutide demonstrates measurable reductions in kidney decline, cardiovascular events, and mortality, clinicians and device manufacturers face a pivotal inflection point, balancing delayed disease progression with the likelihood of more patients ultimately surviving […]
Read more

Sovato Series B signals rising confidence in remote-capable surgical robotics, says GlobalData

Remote-enabled surgical robotics is entering a pivotal growth phase as next-generation platforms integrate teleoperation, advanced imaging, and high-speed connectivity to expand clinical reach. Sovato’s latest Series B financing reinforces this momentum, reflecting rising investor confidence in digitally integrated systems that enhance access, precision, and workflow efficiency, signalling a broader shift toward robotics technologies poised to […]
Read more

Japan ultrasound systems market to reach $1.265 billion in 2034, forecasts GlobalData

Japan’s medical imaging field is progressing steadily with broader adoption of ultrasound diagnostic systems. Within this context, Japan’s ultrasound systems market is projected to reach $1.265 billion in 2034, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Ultrasound Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to […]
Read more

Asia-Pacific nuclear imaging agents market set to reach $1,105 million in 2034, forecasts GlobalData

Fueled by an aging population, rising chronic disease burden, and government healthcare investments, the nuclear imaging agents market in the Asia-Pacific region is projected to reach $1,105 million in 2034, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Nuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036,” reveals […]
Read more

Breast Cancer Awareness Month: Early identification can close gap in breast cancer care, says GlobalData

Breast cancer is the most diagnosed cancer in women worldwide. Raising awareness encourages early detection through mammography. As October is Breast Cancer Awareness Month, community outreach should be prioritized to bring awareness to anyone who may be affected by breast cancer. Early detection significantly increases the chances of successful treatment and survival. The stage of […]
Read more

GlobalData highlights potential impact of AI-powered bio-wearables on in vitro diagnostics

The convergence of biosensing and artificial intelligence (AI) is redefining remote patient care, with next-gen bio-wearables enabling continuous molecular monitoring beyond traditional in vitro diagnostics (IVD). The latest $14 million funding round by Adaptyx Biosciences (Adaptyx) for its AI-powered bio-wearable skin patch signals growing investor confidence in technologies that could transform episodic testing into proactive, […]
Read more

Japan biopsy devices market to grow at 3% CAGR through 2036, forecasts GlobalData

With rising cancer prevalence and greater adoption of minimally invasive and image-guided diagnostic procedures, the biopsy devices market in Japan is projected to expand at a compound annual growth rate (CAGR) of 3% through 2036, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions […]
Read more

Diabetes Awareness Month emphasizes the importance of screening, says GlobalData

Diabetes continues to pose a major global health challenge, driving millions of deaths annually and escalating risks of cardiovascular, renal, and vision-related complications. Observed each November, Diabetes Awareness Month underscores the urgent need for early detection, effective management, and equitable access to care, critical measures to curb the disease’s rising prevalence, improve outcomes, and reduce […]
Read more

China new rare earth export controls can disrupt medical device supply chains, says GlobalData

China’s decision to expand export controls on 12 rare earth metals, which are critical for the manufacturing of magnetic resonance imaging (MRI) scanners, X-ray systems, and laser surgery devices, poses new risks for global medical device supply chains. With China dominating rare earth refinement, the tightened restrictions could disrupt production, delay innovation, and slow market […]
Read more

BVI Medical to gain compelling launch point to expand in IOL market with FineVision HP approval, says GlobalData

BVI Medical has gained FDA approval for the FineVision HP, the world’s first trifocal intraocular lens for cataract surgery. The approval allows the company to expand coverage in the intraocular lens (IOL) market and, more specifically, the multifocal IOL market. The FineVision HP patented design offers vision at far, intermediate and near distances providing an […]
Read more

Medtronic US IDE study for Hugo system underscores growing role of robotics in women’s health, says GlobalData

Medtronic has initiated the Embrace Gynecology US investigational device exemption (IDE) study to evaluate the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynecological procedures. The move reflects the increasing importance of robotics and integrated surgical platforms in women’s health and underscores the drive toward more precise, efficient, and patient-centric minimally invasive […]
Read more

Breast Cancer Awareness Month highlights importance of innovation in CDx for personalized medicine, says GlobalData

October is Breast Cancer Awareness Month, and it highlights a disease that affects millions worldwide. In oncology, companion diagnostics (CDx) are particularly valuable because they detect cancer-specific biomarkers in patient samples and thereby guide treatment selection.  They can also be used to monitor patient response to treatment. As a core element of precision medicine, CDx […]
Read more

India dental implants and abutments market to grow at 6% CAGR through 2034, forecasts GlobalData

India’s dental implants and abutments market is entering a decade of structural change, driven less by sheer volume growth and more by a shift in expectations from both patients and practitioners. The conversation is moving away from affordability alone toward reliability, aesthetics, and clinical outcomes. Reflecting this shift, India’s dental implants and abutments market is […]
Read more

India 3T MRI systems market to grow at 12% CAGR through 2036, forecasts GlobalData

India’s medical imaging sector is undergoing rapid transformation with hospitals increasingly adopting advanced magnetic resonance imaging (MRI) systems to improve diagnostic accuracy. Against this backdrop, the 3T MRI systems market in India is anticipated to grow at a compound annual growth rate (CAGR) of approximately 12% between 2024 and 2036, forecasts GlobalData, a leading data […]
Read more

Johnson & Johnson to face fierce competition from Boston Scientific in US electrophysiology device market, says GlobalData

Johnson & Johnson and Boston Scientific are currently the companies with the largest market shares in the US electrophysiology devices market. Johnson & Johnson has held majority market share for over a decade. From Q4 2024 to present, Boston Scientific’s Farawave pulsed field ablation catheter has maintained its place as the highest revenue product line […]
Read more

Japan oncology tests market to register 2% CAGR through 2034, forecasts GlobalData

Japan’s oncology tests market is consolidating its position as a frontrunner in advancing cancer care, underpinned by the country’s growing elderly population and the escalating burden of the disease. As these pressures mount, reliance on the next-generation diagnostic technologies, central to precision oncology, is increasing. Propelled by these factors, the Japan oncology tests market is […]
Read more
1 2 3 4 5 50